Monday, 17 June 2019

Taxifolin Market To Sustain A CAGR of 5.7% Between 2017-2026

New York City, NY: Jun 17, 2019 – Published via (Wired Release) – Taxifolin, also known as dihydroquercetin, is a flavanonol, and is a type of flavonoid, which is highly diversified and multi-substituted subgroup. It is a favorable natural antioxidant and can be found in conifers such as Larix sibirica, Siberian larch, Pinus roxburghii, Cedrus deodara and in the Chinese yew, Taxus chinensis var. mairei. Specifically, taxifolin is found in plant-based foods like fruit, vegetables, wine, tea, and cocoa. It is also found in silymarin extract from the milk thistle seeds, and in vinegars aged in cherry wood. The taxifolin has anti-microbial, antibacterial, antifungal, and anti-inflammatory properties.

The global taxifolin market is estimated to value at around US$ 0.1 Bn in 2018, and is expected to register a CAGR of 5.7%.  The first five-year cumulative revenue (2018–2022) is projected to be over US$ 0.5 Bn, which is expected to increase considerably over the latter part of the five-year forecast period.

Rising demand for taxifolin owing to its therapeutic properties such as anti-oxidative and even anticancer actions, coupled with increasing prevalence of cancer globally are factors expected to propel growth of the target market over the forecast period. Taxifolin can be used in food and cosmetic products instead of flavonoids, which are currently in use today, owing to minimal or no side effects, and is a better anticarcinogen which helps in increasing immunity in individuals.

Taxifolin is gaining traction in various emerging applications such as in sports nutrition, confectioneries, therapeutic dietary supplements, and pharmaceutical products. It is used to treat different diseases, in agriculture applications, as an ingredient in soft drinks and alcoholic beverage, personal care products etc., which is a major factor driving growth of the target market currently.

Request For Sample Report Before Buying (Use Corporate eMail ID to Get Higher Priority): https://marketresearch.biz/report/taxifolin-market/request-sample/

Global Taxifolin Market: Market Forecast

The comprehensive research report comprises a complete forecast of the global taxifolin market based on factors affecting the market and their impact in the foreseeable future. According to the forecast projections, revenue from the global taxifolin market is expected to expand at a moderate CAGR of 5.7% during the forecast period.

Global Taxifolin Market: Segmental Snapshot

The market report has been segmented on the basis of type, application, and region/country. The type segment includes purity <95% and purity ≥95%. By application segment includes food, healthcare products, and medicine. The region/country covered in the analysis are North America, Europe, China, India, Japan, Southeast Asia and Rest of the World.

By Type: The Purity ≥95% segment is expected register higher CAGR of over 5.5% as compared to other type segment. The Purity <95% segment is expected to dominate in the global market over the forecast period.

By Application: The medicine segment is expected register highest CAGR of around 5.8% in the global market

By Region/Country: The market in Europe accounted for highest revenue share in the global taxifolin market in 2017. The market in China is projected to register highest CAGR of over 6% over the forecast period.

Inquire for Further Detailed Information About The Report Before Buying (Use Corporate email ID to Get Higher Priority): https://marketresearch.biz/report/taxifolin-market/#inquiry

Global Taxifolin Market: Competitive Analysis

The research report on the global taxifolin market includes profiles of some of major companies such as Linjiang Jianwei Biotech Co., Ltd., KINGHERBS Limited, JW Health Products Inc., KALENIKA Group, Ametis JSC, and Merck KGaA.

Pricing Details For The Report: (Limited Period Offer) Single User- $3,995 | Multiple User- $6,600 | Corporate Users- $8,200
To Purchase This Premium Report Click Here: https://marketresearch.biz/purchase-report/?report_id=8039

How do Single user, multiple user, and corporate licenses differ from each other?

Single user, multiple user, and corporate licenses are differentiated on the basis of the number of users permitted to use the ordered reports. For a single user license, the distribution of a report copy will be restricted to only one user. Understood by its term, a multiple user license will be restricted to more than one user, typically five users only. Corporate license holders, on the other hand, will be able to distribute a report copy across their organization.

About Us:

MarketResearch.Biz is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge. It offers services such as data mining, information management, and revenue enhancement solutions and suggestions.

Contact Us:

Mr. Benni Johnson

Prudour Pvt. Ltd.

420 Lexington Avenue,

Suite 300 New York City, NY 10170,

United States

Tel: + 1-347-826-1876

Email ID: inquiry@marketresearch.biz

Website: https://marketresearch.biz/



from Wired Release http://bit.ly/2XnV3qm
via gqrds

No comments:

Post a Comment

Global Plasma Protein Therapeutics Market Recent Trends And Demand By Top Key Vendors – Shire (Baxalta), CSL, Grifols

New York City, NY: Oct. 30, 2020-Published via (Wired Release)- Radical Growth of Global Plasma Protein Therapeutics Market Provides an upd...